局限性前列腺癌男性的照护满意度:一项全国性基于人群的研究
瑞典全国性调查纳入2008年诊断的低危前列腺癌≤70岁男性1720例,2015年随访1288例(74.9%)。高照护满意度(OSC)958例(74.4%),与决策参与度高、获得更多信息、信息质量高、有护士导航员及功能结局好相关;随访由医生或专科护士进行不影响OSC。
要点
- 低危前列腺癌男性中74.4%报告高照护满意度。
- 信息与决策参与是照护满意度的关键因素,与治疗方式无关。
- 主动监测男性较高参与决策、获得更多信息的比例低于手术或放疗组。
核心结论
- 信息和决策参与以及获得护士导航员是照护满意度的关键因素,与治疗方式无关。
- 主动监测男性需要更多治疗信息和更多决策参与。
- 护士主导随访与医生主导随访的照护满意度一样高。
研究设计与样本
- 全国性基于人群的调查,纳入瑞典国家前列腺癌登记处2008年诊断的低危前列腺癌≤70岁男性1720例,2015年邀请参与。
- 接受根治性前列腺切除术、放疗或开始主动监测的男性纳入分析。
- 采用序贯逻辑回归分析照护满意度数据,计算最高与最低可能反应类别比较的比值比(OR)。
主要发现
- 1288例男性(74.9%)回应,958例(74.4%)报告高照护满意度。
- 高照护满意度相关因素:决策参与度高(OR 4.18,95%CI 2.61-6.69)、获得更多信息(OR 11.1,95%CI 7.97-15.6)、信息质量高(OR 7.85,95%CI 5.46-11.3)、有护士导航员(OR 1.80,95%CI 1.44-2.26)、功能结局更好(EPIC-26问卷高25分;OR 1.34,95%CI 1.21-1.48)。
- 随访由医生或专科护士进行不影响照护满意度(OR 0.84,95%CI 0.66-1.07)。
- 根治性前列腺切除术组、放疗组与主动监测组报告高照护满意度分别为78.2%、84.0%、72.6%,高决策参与分别为70.5%、64.5%、49.2%,获得更多信息分别为40.5%、45.8%、28.6%,认为会死于前列腺癌分别为3.8%、3.9%、8.0%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 非随机回顾性设计。
- 可能存在回忆偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Information about how men with prostate cancer (PC) experience their medical care and factors associated with their overall satisfaction with care (OSC) is limited. OBJECTIVE: To investigate OSC and factors associated with OSC among men with low-risk PC. DESIGN, SETTING, AND PARTICIPANTS: Men registered in the National Prostate Cancer Register of Sweden as diagnosed in 2008 with low-risk PC at the age of ≤70 yr who had undergone radical prostatectomy (RP), radiotherapy (RT), or started on active surveillance (AS) were invited in 2015 to participate in this nationwide population-based survey (n=1720). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: OSC data were analysed using ordinal logistic regression. Odds ratios (ORs) were calculated for comparisons between the highest and lowest possible response categories. RESULTS AND LIMITATIONS: A total of 1288 men (74.9%) responded. High OSC was reported by 958 (74.4%). Factors associated with high OSC were high participation in decision-making (OR 4.18, 95% confidence interval [CI] 2.61-6.69), receiving more information (OR 11.1, 95% CI 7.97-15.6), high-quality information (OR 7.85, 95% CI 5.46-11.3), access to a nurse navigator (OR 1.80, 95% CI 1.44-2.26), and better functional outcomes (defined as 25 points higher on the EPIC-26 questionnaire; OR 1.34, 95% CI 1.21-1.48). OSC was not affected by whether a doctor or specialist nurse conducted follow-up (OR 0.84, 95% CI 0.66-1.07). These findings were similar across treatment groups. Men who had undergone RP or RT reported high OSC more often than men on AS (78.2% vs 84.0% vs 72.6%), high participation in decision-making (70.5% vs 64.5% vs 49.2%), and having received more information (40.5% vs 45.8% vs 28.6%), and were less likely to believe they would die from PC (3.8% vs 3.9% vs 8.0%). Limitations include the nonrandomised retrospective design and potential recall bias. CONCLUSIONS: Information and participation in decision-making, as well as access to a nurse navigator, are key factors for OSC, regardless of treatment. Men on AS need more information about their treatment and need to participate more in decision-making. OSC was as high among men who had nurse-led follow-up as among men who had doctor-led follow-up. PATIENT SUMMARY: Information about how men with low-risk prostate cancer experience their medical care is limited. In this nationwide population-based study we found that information and participation in decision-making as well as access to a nurse navigator are key factors for satisfaction regardless of treatment. Men who are being closely watched for prostate cancer without immediate curative treatment need more information than they now receive and need to participate more in decision-making than they currently do.
引用
- Bergengren O, Garmo H, Bratt O, et al. Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study. Eur Urol Oncol. 2018. PMID: 31100227. doi:10.1016/j.euo.2018.02.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。